Katalin Dobra

Solna, AB 17164, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Screening for anal high-grade squamous intraepithelial lesions with flexible endoscopy in high-risk individuals.

Screening for anal high-grade squamous intraepithelial lesions with flexible endoscopy in high-risk individuals.

Journal: Scandinavian journal of gastroenterology
Published: June 01, 2026

Cancer-Associated Fibroblasts Move and Interact More with Triple-Negative Breast Cancer Cells and Stimulate Their Proliferation in a Hyaluronan-Dependent Manner.

Cancer-Associated Fibroblasts Move and Interact More with Triple-Negative Breast Cancer Cells and Stimulate Their Proliferation in a Hyaluronan-Dependent Manner.

Journal: Cells
Published: August 30, 2025

A Subphase-Labeled Mitotic Dataset for AI-powered Cell Division Analysis.

A Subphase-Labeled Mitotic Dataset for AI-powered Cell Division Analysis.

Journal: Scientific data
Published: July 28, 2025

Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response.

Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response.

Journal: Cancers
Published: June 01, 2025

Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis.

Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis.

Journal: Cancers
Published: January 31, 2025

The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells.

The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells.

Journal: Cancers
Published: November 17, 2024

An Evaluation Into the Robustness of Grading of Pleural Mesothelioma Outside of Specialist Centres.

An Evaluation Into the Robustness of Grading of Pleural Mesothelioma Outside of Specialist Centres.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: March 22, 2024

Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.

Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.

Journal: Cytopathology : official journal of the British Society for Clinical Cytology
Published: March 30, 2023

Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells.

Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells.

Journal: Haematologica
Published: January 04, 2023

Utility of BerEp4/calretinin and desmin/epithelial membrane antigen (EMA) dual immunocytochemical staining in effusion cytology.

Utility of BerEp4/calretinin and desmin/epithelial membrane antigen (EMA) dual immunocytochemical staining in effusion cytology.

Journal: Cancer medicine
Published: August 29, 2022

PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations.

PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations.

Journal: International journal of molecular sciences
Published: March 25, 2022

Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics.

Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics.

Journal: Biomolecules
Published: October 06, 2021
Showing 1-12 of 55

Last Updated: 09/26/2026